Author:
He Guangda,Jiang Meijie,Tian Sifan,He Linkang,Bai Xueke,Chen Shi,Li Guangyu,Wang Chunqi,Zhang Zenglei,Wu Yi,Su Mingming,Li Xiangjie,Guo Xinxin,Yang Yang,Zhang Xiaoyan,Cui Jianlan,Xu Wei,Song Lijuan,Yang Hao,He Wenyan,Zhang Yan,Li Xi,Gao Xu,Chen Liang
Reference57 articles.
1. Atherosclerosis;Libby;Nat Rev Dis Prim,2019
2. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the american college of cardiology/american heart association task force on clinical practice guidelines;Grundy;Circulation,2019
3. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020
4. Repositioning of the global epicentre of non-optimal cholesterol;Nature,2020
5. Prevalence of dyslipidemia and availability of lipid-lowering medications among primary health care settings in China;Lu;JAMA Netw Open,2021